Geraldine Mcelroy, in Canton, MS - Advanced Practice Midwife

Geraldine Mcelroy, is a Advanced Practice Midwife based in Canton, Mississippi. Geraldine Mcelroy is licensed to practice in Mississippi (license number R626716) and her current practice location is 317 N Union St, Canton, Mississippi. She can be reached at her office (for appointments etc.) via phone at (601) 859-3316.

NPI number for Geraldine Mcelroy is 1942344866 and her current mailing address is 317 N Union St, Canton, Mississippi. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1942344866.

Contact Information

	Geraldine Mcelroy,
	317 N Union St, Canton, MS 39046-3730
	(601) 859-3316
	Not Available

Provider's Profile

Full Name	Geraldine Mcelroy
Gender	Female
Speciality	Advanced Practice Midwife
Location	317 N Union St, Canton, Mississippi
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1942344866
Provider Enumeration Date: 02/16/2007
Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Geraldine Mcelroy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942344866	NPI	-	NPPES
00124250	Medicaid	MS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	R626716 (Mississippi)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Geraldine Mcelroy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Geraldine Mcelroy, 317 N Union St, Canton, MS 39046-3730 Ph: (601) 859-3316	Geraldine Mcelroy, 317 N Union St, Canton, MS 39046-3730 Ph: (601) 859-3316

News Archive

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).

Study shows safety and efficacy of radio-wave therapy for liver cancer patients

Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

T2-weighted BLADE MR sequence helps radiologists more accurately evaluate abnormalities of the uterus and ovaries

A new MR imaging sequence, T2-weighted BLADE, used to image the female pelvis improves image quality and helps radiologists make a more accurate diagnosis, according to a study performed at the University of Maryland School of Medicine in Baltimore, MD.

At local level, Komen affiliates express concern about decision

In California, seven Komen groups ask the national breast cancer group to reverse its funding decision. Others report concerns about community support for future money-raising activities.

Geraldine Mcelroy, - Advanced Practice Midwife in Canton, MS